We are global company, don't accuse us of inexperience: Bharat Biotech sends strong message to critics
The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin was yesterday given 'restricted use in emergency situation in public interest' - hit out today at critics querying the lack of Phase III trial data and others questioning the drug's efficacy.